Cultural Exchange in Chinese Medicine, Promoting Collateral Disease Theory

On November 9th, the inauguration meeting of the Taiwan Collateral Disease Association and the World Summit on Liaison Disease Professional Committee was held at Taipei Medical University. Academician Wu Yiling, an academician of the Chinese Academy of Engineering and the founder of the collateral disease discipline, and nearly 500 experts from the pharmaceutical industry from around the world Scholars came to the conference to contribute to the promotion of academic exchanges between the two sides of the Taiwan Strait and the promotion of TCM disease in Taiwan.

As an important part of TCM theory, collateral disease has important guiding value for the treatment of modern refractory diseases. The Academician Wu Yiling, the president of the World Federation of Chinese Medicine Societies and the Chairman of the Collaborative Diseases Committee, has always been committed to the theoretical research of collateral diseases in Chinese medicine. For the first time in the history of the development of Chinese medicine, he has developed a theory of systemic collaterals, and he has constructed a new theory of contextology for cardiovascular and cerebrovascular diseases. Modern major diseases such as diabetic nephropathy and malignant tumors have great guiding significance. As the chief scientist, Wu Yiling twice took on the national 973 project on collateral disease research. Through the establishment of a “collateral disease diagnosis and treatment system”, he won the second prize for national scientific and technological progress in 2006 and was approved by the State Administration of Traditional Chinese Medicine in 2009 as a key discipline and advantage. Subject. The "Colonial Diseases" edited by Academician Wu Yiling has become a textbook for undergraduate and graduate students in more than 40 higher TCM colleges and Singapore College of Traditional Chinese Medicine. It has established a national-level secondary disease branch and 28 provinces and municipalities collaterals special committee, Europe and Canada. Other countries and regions have also established a society of disease. Based on the theory of collateral diseases, a number of state-level new drugs, such as Tongxinluo capsules for cardiovascular and cerebrovascular diseases, Shensongyangxin capsules for treating arrhythmia, and Zhiqiangxin capsules for heart failure, have been developed and become essential medicines in China. , market best-selling products. Evidence-based medical research conducted in accordance with international standards also demonstrated the exact efficacy and safety of these drugs. He has won 3 national awards for scientific and technological progress and 1 national second prize for technological inventions. This establishment of the Society of Chinese Medicinal Diseases in Taiwan marks the outcome of these studies will benefit Taiwan compatriots.

Dr. Huang Shuzhen, director of the Taiwan Society of Collateral Diseases, introduced that Chinese medicine is a treasure of the Chinese nation. Chinese medicine in the mainland and Taiwan share the same source, and Taiwanese people have a very high degree of recognition of the concept of TCM, syndrome differentiation, and treatment of diseases. The Chinese medicine industry has developed rapidly and has a high penetration rate. Unfortunately, there is a lack of innovation. This time, the establishment of the Taiwan Collaborative Disease Society will bring the most cutting-edge innovations of Chinese medicine to Taiwan and will greatly promote the academic innovation of Chinese medicine in Taiwan.

As a platform for cross-strait network disease research experts and scholars' academic exchanges, the Taiwan Collaborative Disease Society takes the health of compatriots on both sides of the Strait as a starting point and complements each other. It will certainly bring new impetus to the development of TCM in Taiwan and provide a variety of practical services for Taiwanese people. Health knowledge and high-quality medical service projects will jointly make the cross-strait TCM business bigger and stronger.